10 research outputs found
Senescent human fibroblasts selectively secrete miRNAs in extracellular vesicles and modulate keratinocyte functionality during skin aging.
Blocking negative effects of senescence in human skin fibroblasts with a plant extract.
Dermatology-oncolog
SNEV<sup>hPrp19/hPso4</sup> regulates adipogenesis of human adipose stromal cells.
Aging is accompanied by loss of subcutaneous adipose tissue. This may be due to reduced differentiation capacity or deficiency in DNA damage repair (DDR) factors. Here we investigated the role of SNEVhPrp19/hPso4, which was implicated in DDR and senescence evasion, in adipogenic differentiation of human adipose stromal cells (hASCs). We showed that SNEV is induced during adipogenesis and localized both in the nucleus and in the cytoplasm. Knockdown of SNEV perturbed adipogenic differentiation and led to accumulation of DNA damage in hASCs upon oxidative stress. In addition, we demonstrated that SNEV is required for fat deposition in Caenorhabditis elegans. Consequently, we tested other DDR factors and found that WRN is also required for adipogenesis in both models. These results demonstrate that SNEV regulates adipogenesis in hASCs and indicate that DDR capacity in general might be a pre-requisite for this process
Small extracellular vesicles and their miRNA cargo are anti-apoptotic members of the senescence-associated secretory phenotype.
Loss of functionality during aging of cells and organisms is caused and accompanied by altered cell-to-cell communication and signalling. One factor thereby is the chronic accumulation of senescent cells and the concomitant senescence-associated secretory phenotype (SASP) that contributes to microenvironment remodelling and a pro-inflammatory status. While protein based SASP factors have been well characterized, little is known about small extracellular vesicles (sEVs) and their miRNA cargo. Therefore, we analysed secretion of sEVs from senescent human dermal fibroblasts and catalogued the therein contained miRNAs. We observed a four-fold increase of sEVs, with a concomitant increase of > 80% of all cargo miRNAs. The most abundantly secreted miRNAs were predicted to collectively target mRNAs of pro-apoptotic proteins, and indeed, senescent cell derived sEVs exerted anti-apoptotic activity. In addition, we identified senescencespecific differences in miRNA composition of sEVs, with an increase of miR-23a-5p and miR-137 and a decrease of miR-625-3p, miR-766-3p, miR-199b-5p, miR-381-3p, miR-17-3p. By correlating intracellular and sEV-miRNAs, we identified miRNAs selectively retained in senescent cells (miR-21-3p and miR-17-3p) or packaged specifically into senescent cell derived sEVs (miR-15b-5p and miR-30a-3p). Therefore, we suggest sEVs and their miRNA cargo to be novel, members of the SASP that are selectively secreted or retained in cellular senescence
CD38 deficiency alleviates Ang II-induced vascular remodeling by inhibiting small extracellular vesicle-mediated vascular smooth muscle cell senescence in mice
FASN activity is important for the initial stages of the induction of senescence
Senescent cells accumulate in several tissues during ageing and contribute to several pathological processes such as
ageing and cancer. Senescence induction is a complex process not well defined yet and is characterized by a series of
molecular changes acquired after an initial growth arrest. We found that fatty acid synthase (FASN) levels increase
during the induction of senescence in mouse hepatic stellate cells and human primary fibroblasts. Importantly, we also
observed a significant increase in FASN levels during ageing in mouse liver tissues. To probe the central role of FASN in
senescence induction, we used a small-molecule inhibitor of FASN activity, C75. We found that C75 treatment
prevented the induction of senescence in mouse and human senescent cells. Importantly, C75 also reduced the
expression of the signature SASP factors interleukin 1α (IL-1α), IL-1β and IL-6, and suppressed the secretion of small
extracellular vesicles. These findings were confirmed using a shRNA targeting FASN. In addition, we find that FASN
inhibition induces metabolic changes in senescent cells. Our work underscores the importance of C75 as a
pharmacological inhibitor for reducing the impact of senescent cell accumulationChildren with Cancer UK (Number: 14–178)BBSRC (BB/P000223/1)The Royal Society (RG170399)Nacional Health Institute Carlos IIIMiguel-Servet (CP13-00234)MINECO (SAF2016-78666 R